News
World first medical device implantation to restore erectile function
21 August 2023PRESS RELEASE A world first implantation of a high-tech, battery-powered device to restore erectile function, has taken place at the Royal Melbourne Hospital (RMH) leading...
Read more
Comphya SA Launches Groundbreaking Clinical Study for Erectile Dysfunction Treatment in Spinal Cord Injury Patients in Brazil
10 July 2023PRESS RELEASE Lausanne, Switzerland, July 10th, 2023 – Comphya SA, a pioneering medical technology company, is excited to announce the initiation of a groundbreaking clinical...
Read more
Comphya SA Commences Recruitment for Pilot Clinical Study in Prostatectomy Patients
05 June 2023PRESS RELEASE Lausanne, Switzerland, June 5th, 2023 - Comphya SA and the Australian Prostate Centre (APC) to announce the initiation of a pioneering pilot clinical...
Read more
Comphya receives approval for first pilot clinical trial in Australia
02 March 2023PRESS RELEASE Lausanne, Switzerland, March 2nd, 2023. Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), announced today that Australian regulatory authorities...
Read more
Comphya successfully raises additional funds for pilot clinical trials
31 January 2023PRESS RELEASE Lausanne, Switzerland, January 31st, 2023. Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), today announced the fundraising of CHF...
Read more
Comphya adds top clinicians as advisors
29 September 2022PRESS RELEASE A pioneer in robotic surgery and two leading authorities in men’s sexual health join Comphya’s Clinical Advisory Board. This gives the startup a...
Read more
Low-intensity electrostimulation reestablishes erectile function after prostatectomy
16 March 2022PRESS RELEASE A study published in the Journal of Sexual Medicine shows that Comphya’s implantable neurostimulator does not only allow on-demand penile erection, but could...
Read more
Comphya announces that two new patents have been granted in the U.S. for the CaverSTIM system
02 December 2021PRESS RELEASE Lausanne, Switzerland, December 02nd, 2021. Comphya SA, a medical device company focusing on the treatment of erectile dysfunction by neuromodulation for non-responders to...
Read more
Comphya has received ISO 13485 certification for the design, development, manufacture and sterilization
28 October 2021PRESS RELEASE Lausanne, Switzerland, October 28th, 2021. Comphya announces that it has received the ISO 13485 certificate for Medical Device and Quality Management Systems. The...
Read more
Comphya strengthens its team with the appointment of Pierre Chauvineau as new Board of Director
10 February 2021PRESS RELEASE Lausanne, Switzerland, February 10th, 2021. Comphya SA, the developer of CaverSTIM, the first implantable neurostimulator to restore erectile function in non-responders to oral...
Read more